Key facts
- Setsuro Tech’s last known valuation is $18.0M (Jan 2026).
- It has raised $10.3M; the latest was Later Stage VC ($2.3M) in Jan 2026.
- Notable investors include SBI Investment, Intellectual Property Acceleration Program for Startups, Awa Bank Consulting, Awagin Capital, Business Creation Capital — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Setsuro Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for Setsuro Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Setsuro Tech
Provider of biotechnology research and development services intended to produce genetically modified mice. The company uses the fertilized egg electroporation method to help in the genomic editing of fertilized eggs with high throughput by the electric force, enabling clients to receive support in creating and selling genetically modified mice.
- Sector
- Healthcare
- HQ
- Tokushima City, Japan
- Founded
- 2017
- Employees
- 3
- Website
- setsurotech.com/
- Ownership
- Privately Held (backing)
Setsuro Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Setsuro Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Setsuro Tech in its N-PORT filings yet. We sweep new filings monthly.